ERBB2 and neoplasm: First and foremost, HER2 overexpression criteria (IHC 3+), set in DESTINY-PanTumor02, differs significantly from traditional tumor types such as breast, gastric/GEJ, and colorectal cancers (Figure 1) (34, 36).